Valeant sees smaller deals, discussing merger of equals

Wed Aug 7, 2013 9:22am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 7 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, continues to discuss a potential merger of equals, and also expects to be active for the rest of 2013 with smaller acquisitions, Chief Executive Michael Pearson said.

Completing a merger of equals "can't be predicted," Pearson said on Wednesday during a conference call to discuss second-quarter results.